Jimmy Zhenli Liu
Epidemiology · 2010–2019
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Epidemiology — 10 citations into it
- Immunology — 9 citations into it
- Surgery — 8 citations into it
Whom Jimmy Zhenli Liu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jimmy Zhenli Liu overall
Papers from Jimmy Zhenli Liu's perspective
Ordered by how strongly the researchers Jimmy Zhenli Liu trusts endorse each paper. Same corpus, a different order for every researcher.
- The support of human genetic evidence for approved drug indications (Nature Genetics)
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (The Lancet)
- The future of association studies: gene-based analysis and replication. (American Journal of Human Genetics)
- Validating therapeutic targets through human genetics
- Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease (Nature Genetics)
- Genomic atlas of the human plasma proteome (Nature)
- Connecting genetic risk to disease end points through the human blood plasma proteome (Nature Communications)
- The druggable genome and support for target identification and validation in drug development (Science Translational Medicine)
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
- Clinical development success rates for investigational drugs (Nature Biotechnology)
Their papers
- Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases (2019) — 633 citations
- Genetic variants associated with subjective well-being, depressive symptoms and neuroticism identified through genome-wide analyses (2016) — 986 citations
- Detection and interpretation of shared genetic influences on 42 human traits (2016) — 1,123 citations
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations (2015) — 2,354 citations
- A versatile gene-based test for genome-wide association studies. (2010) — 843 citations